Literature DB >> 18539973

Brain tumor stem cells: bringing order to the chaos of brain cancer.

Peter B Dirks1.   

Abstract

Brain tumors are generally incurable cancers. Work from a number of laboratories strongly suggests that they are organized as a hierarchy based on a subset of cancer cells that have stem-cell properties. These cells have now been shown to be resistant to conventional therapy and responsive to differentiation therapy. New in vitro and in vivo models for interrogating brain tumor cells in stem-cell conditions have been developed that provide important new opportunities for elucidating the key pathways responsible for driving the proliferation of these cells. Continued application of the principles of stem-cell biology to the study of brain cancers is likely to continue to bring further important insight into these aggressive cancers, bringing new treatments and understanding of the origins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539973     DOI: 10.1200/JCO.2008.17.6792

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  65 in total

1.  Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells.

Authors:  Christine E Brown; Renate Starr; Brenda Aguilar; Andrew F Shami; Catalina Martinez; Massimo D'Apuzzo; Michael E Barish; Stephen J Forman; Michael C Jensen
Journal:  Clin Cancer Res       Date:  2012-03-08       Impact factor: 12.531

2.  Cortical dysplasia: a possible substrate for brain tumors.

Authors:  Shiyong Liu; Chunqing Zhang; Haifeng Shu; Didier Wion; Hui Yang
Journal:  Future Oncol       Date:  2012-03       Impact factor: 3.404

3.  Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients.

Authors:  Candace M Howard; Jagan Valluri; Anthony Alberico; Terrence Julien; Rida Mazagri; Robert Marsh; Hoyt Alastair; Antonio Cortese; Michael Griswold; Wanmei Wang; Krista Denning; Linda Brown; Pier Paolo Claudio
Journal:  Transl Oncol       Date:  2017-02-12       Impact factor: 4.243

4.  Stem cells, radial glial cells, and a unified origin of brain tumors.

Authors:  M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-01       Impact factor: 3.825

5.  Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.

Authors:  Karina Kristoffersen; Mette Kjølhede Nedergaard; Mette Villingshøj; Rehannah Borup; Helle Broholm; Andreas Kjær; Hans Skovgaard Poulsen; Marie-Thérése Stockhausen
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

Review 6.  Glioblastoma stem cells: Molecular characteristics and therapeutic implications.

Authors:  Nermin Sumru Bayin; Aram Sandaldjian Modrek; Dimitris George Placantonakis
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

7.  Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential.

Authors:  Marie-Thérése Stockhausen; Karina Kristoffersen; Louise Stobbe; Hans Skovgaard Poulsen
Journal:  Cancer Biol Ther       Date:  2013-11-01       Impact factor: 4.742

8.  Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation.

Authors:  Ki-Chun Yoo; Yongjoon Suh; Yoojeong An; Hae-June Lee; Ye Ji Jeong; Nizam Uddin; Yan-Hong Cui; Tae-Hoon Roh; Jin-Kyoung Shim; Jong Hee Chang; Jong Bae Park; Min-Jung Kim; In-Gyu Kim; Seok-Gu Kang; Su-Jae Lee
Journal:  Oncogene       Date:  2018-03-21       Impact factor: 9.867

9.  Decreasing glioma recurrence through adjuvant cancer stem cell inhibition.

Authors:  Josh Neman; Rahul Jandial
Journal:  Biologics       Date:  2010-06-24

Review 10.  The bright and the dark sides of DNA repair in stem cells.

Authors:  Guido Frosina
Journal:  J Biomed Biotechnol       Date:  2010-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.